Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

News

Premier Inc. Honors Indiana Recovery Home for Women with National Award and $100,000 Prize: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier Inc. Honors Indiana Recovery Home for Women with National Award and $100,000 Prize


The BreakAway, a nonprofit dedicated to helping women recover from the disease of addiction in New Albany, IN, has received the 2022 Monroe E. Trout Premier Cares Award and a $100,000 cash prize

Henry Ford Health Wins 2022 Premier Alliance Excellence Award: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Henry Ford Health Wins 2022 Premier Alliance Excellence Award


Premier, Inc. (NASDAQ: PINC), a leading healthcare improvement and technology company, has named Henry Ford Health, an integrated nonprofit health system providing a full continuum of services

Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields Together with KEYTRUDA® for Patients with First-Line Stage III Non-Small Cell Lung Cancer: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure Enrolls First Patient in KEYNOTE-B36, a Pilot Study of Tumor Treating Fields Together with KEYTRUDA® for Patients with First-Line Stage III Non-Small Cell Lung Cancer


Novocure (NASDAQ: NVCR) today announced the first patient has been enrolled in its phase 2 pilot KEYNOTE-B36 study, conducted in collaboration with MSD, a tradename of Merck & Co., Inc., Rahway

AMN Healthcare Services, Inc. Announces $250 Million Share Repurchase Program: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Services, Inc. Announces $250 Million Share Repurchase Program


The Board of Directors (the “Board”) of AMN Healthcare Services, Inc. (NYSE: AMN, the “Company”) authorized an additional $250 million under the Company’s repurchase program for the company’s

Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A


Charles River Laboratories International, Inc. (NYSE: CRL) and ASC Therapeutics, a privately held biopharmaceutical company pioneering the development of transformative in vivo gene replacement

Charles River Laboratories to Participate in Jefferies and William Blair Conferences: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River Laboratories to Participate in Jefferies and William Blair Conferences


Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies Healthcare Conference on Wednesday, June 8th, at 10:00 a.m. ET, and at the William

Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Fields Together with Standard-of-Care Chemotherapy Meets Primary Endpoint for First-Line Treatment of Gastric Cancer: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure and Zai Lab Announce EF-31 Phase 2 Pilot Study Evaluating Tumor Treating Fields Together with Standard-of-Care Chemotherapy Meets Primary Endpoint for First-Line Treatment of Gastric Cancer


Novocure (NASDAQ: NVCR), a global oncology company working to extend survival in some of the most aggressive forms of cancer, and Zai Lab (NASDAQ: ZLAB; HKEX: 9688), an innovative commercial-stage

Chemed Corporation to Present at the Jefferies 2022 Healthcare Conference:
Chemed Corporation to Present at the Jefferies 2022 Healthcare Conference


Chemed Corporation (NYSE: CHE) today announced that it will deliver a presentation at the Jefferies 2022 Healthcare Conference on Thursday, June 9, 2022, at approximately 8:00 a.m. (ET) in New York

AMN Healthcare Survey: Most Healthcare Facilities Using Locum Tenens Physicians to Fill Vacancies: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Survey: Most Healthcare Facilities Using Locum Tenens Physicians to Fill Vacancies


Nearly 90% of healthcare facilities used locum tenens physicians and/or advanced practice professionals to fill gaps in their staffs last year, according to a new survey from AMN Healthcare, the

Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®104, PD-1 x ICOS Bispecific Antibody, in Advanced Solid Tumors: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor Reports Initial Dose-Escalation Data from Phase 1 Study of XmAb®104, PD-1 x ICOS Bispecific Antibody, in Advanced Solid Tumors


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported initial

AMN Healthcare Honored as Prime Supplier of the Year for Work with Minority-Owned Businesses: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Honored as Prime Supplier of the Year for Work with Minority-Owned Businesses


AMN Healthcare, the nation’s leader in healthcare total talent solutions, has been named Prime Supplier of the Year by the Western Regional Minority Supplier Development Council for prioritizing

Novocure Announces Clinical Collaboration with MSD on a Registrational-Intent Study to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Newly Diagnosed Glioblastoma: https://mms.businesswire.com/media/20191120005453/en/721126/5/novocure_main%405x.jpg
Novocure Announces Clinical Collaboration with MSD on a Registrational-Intent Study to Evaluate Tumor Treating Fields Together with KEYTRUDA® (pembrolizumab) in Newly Diagnosed Glioblastoma


Novocure (NASDAQ: NVCR) today announced it has entered into a clinical trial collaboration agreement with MSD, a tradename of Merck & Co., Inc., Rahway, NJ, USA, to study the use of Tumor Treating

AMN Highest Ranked Healthcare MSP in 2022 Global Customer Satisfaction Awards: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Highest Ranked Healthcare MSP in 2022 Global Customer Satisfaction Awards


AMN Healthcare (NYSE: AMN), the nation’s leader in healthcare total talent solutions, achieved the highest ranking for a healthcare Managed Services Program in the HRO Today 2022 Baker’s Dozen

AMN Healthcare Acquires Connetics USA, an International Nurse and Allied Recruitment Company: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Acquires Connetics USA, an International Nurse and Allied Recruitment Company


AMN Healthcare (NYSE: AMN), the nation’s leading total healthcare talent solutions company, has acquired Connetics USA, an international nurse and allied recruitment company that specializes in

Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend:
Chemed Corporation Holds Annual Meeting of Stockholders; Board Declares Quarterly Dividend


Stockholders of Chemed Corporation (NYSE:CHE) today elected a slate of 10 directors at the Company’s 2022 annual stockholders’ meeting. Each of the directors continues from the prior term.

Chemed Corporation to Present at the 2022 RBC Capital Markets Global Healthcare Conference:
Chemed Corporation to Present at the 2022 RBC Capital Markets Global Healthcare Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the RBC Capital Markets Global Healthcare Conference on Wednesday, May 18, 2022, at approximately 8:00 a.m. (ET)

AMN Healthcare Announces First Quarter 2022 Results: https://mms.businesswire.com/media/20201201005032/en/841855/5/AMN-Logo.jpg
AMN Healthcare Announces First Quarter 2022 Results


AMN Healthcare Services, Inc. (NYSE: AMN), the leader and innovator in total talent solutions for healthcare organizations across the United States, today announced its first quarter 2022 financial

Xencor Reports First Quarter 2022 Financial Results: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor Reports First Quarter 2022 Financial Results


Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today reported financial

Acadia Healthcare to Present at May Conferences: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare to Present at May Conferences


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced that the Company will present at two healthcare conferences in May.



On Wednesday, May 11, 2022, the Company will present at the BofA

Premier Inc. to Participate in BofA Securities 2022 Healthcare Conference on May 10, 2022: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier Inc. to Participate in BofA Securities 2022 Healthcare Conference on May 10, 2022


Premier Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, announced today that members of its management team are scheduled to participate in a fireside chat at the

Charles River Laboratories Announces First-Quarter 2022 Results: https://mms.businesswire.com/media/20191106005189/en/754630/5/charles_river_logo.jpg
Charles River Laboratories Announces First-Quarter 2022 Results


Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2022. For the quarter, revenue was $913.9 million, an increase of 10.8% from $824.6

Acadia Healthcare Reports First Quarter 2022 Results: https://mms.businesswire.com/media/20200504005676/en/583255/5/ACHC.jpg
Acadia Healthcare Reports First Quarter 2022 Results


Acadia Healthcare Company, Inc. (NASDAQ: ACHC) today announced financial results for the first quarter ended March 31, 2022.



First Quarter Highlights




  • Revenue totaled $616.7 million, an

Chemed Corporation to Present at the Bank of America Merrill Lynch 2022 Health Care Conference:
Chemed Corporation to Present at the Bank of America Merrill Lynch 2022 Health Care Conference


Chemed Corporation (NYSE:CHE) today announced that it will deliver a presentation at the Bank of America Merrill Lynch 2022 Health Care Conference on Tuesday, May 10, 2022, at 9:20 AM (PDT) at the

Premier, Inc. Reports Fiscal-Year 2022 Third-Quarter Results: https://mms.businesswire.com/media/20191105005372/en/754182/5/PR_LogoSpec_%282%29.jpg
Premier, Inc. Reports Fiscal-Year 2022 Third-Quarter Results


Premier, Inc. (NASDAQ: PINC), a leading technology-driven healthcare improvement company, today reported financial results for the fiscal year 2022 third quarter ended March 31, 2022.



"As we

Xencor to Host First Quarter 2022 Financial Results Webcast and Conference Call on May 5, 2022: https://mms.businesswire.com/media/20191105006084/en/713581/5/Xencor_RGB_fullcolor.jpg
Xencor to Host First Quarter 2022 Financial Results Webcast and Conference Call on May 5, 2022


Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced that it